HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nivea

This article was originally published in The Rose Sheet

Executive Summary

Q10 Wrinkle Control line-up, bowing in February, aims to reduce the appearance of wrinkles by replacing lost Q10 coenzymes in aging skin, the company explained. The collection includes face creme and eye creme housed in plain 1.7 oz. white jars with metallic accents; each product will retail for $10.95. A Q10 Wrinkle Control night creme will be added in June. Since Wrinkle Control works by boosting the amount of the coenzyme in the skin rather than through exfoliation, the company hopes that the products will appeal to consumers who experience irritation from retinol and hydroxy acid products. The collection is already a best-seller in Europe, Nivea noted

You may also be interested in...



Nivea Silky Shimmer Lotion Adds Sparkle To Body Portfolio

Nivea is adding Silky Shimmer Lotion to its body care portfolio in an effort to attract prestige shoppers to the mass market, Beiersdorf said, maintaining the product is the first of its kind in mass outlets

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS006210

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel